Yu Yong 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Yu Yong（CIK 1937482）在 1 家公司共报告 9 笔 SEC Form 4 内部人交易（最近一笔 2026-09-02）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-02 | GENELUX Corp (GNLX) | Chief Scientific Officer | 卖出 | 9,683 | $26,658 |
| 2026-08-04 | GENELUX Corp (GNLX) | Chief Scientific Officer | 卖出 | 653 | $1,922 |
| 2026-06-18 | GENELUX Corp (GNLX) | Chief Scientific Officer | 买入 | 119,318 | $0 |
| 2026-05-12 | GENELUX Corp (GNLX) | Chief Scientific Officer | 卖出 | 605 | $1,797 |
| 2026-03-26 | GENELUX Corp (GNLX) | SVP, Clinical Development | 卖出 | 906 | $2,193 |
| 2025-12-11 | GENELUX Corp (GNLX) | SVP, Clinical Development | 卖出 | 3,219 | $10,816 |
| 2025-12-11 | GENELUX Corp (GNLX) | SVP, Clinical Development | 卖出 | 973 | $5,225 |
| 2025-08-29 | GENELUX Corp (GNLX) | SVP, Clinical Development | 买入 | 101,480 | $0 |
| 2025-05-13 | GENELUX Corp (GNLX) | VP, Clinical Trial Operations | 卖出 | 5,579 | $16,291 |
来源：SEC Form 4 申报文件 · 截至 2026-09-02